Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WAPPENSCHMIDT, Barbara")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 21 of 21

  • Page / 1
Export

Selection :

  • and

Genetic variants within miR-126 and miR-335 are not associated with breast cancer riskRONGXI YANG; DICK, Michelle; SCHOTT, Sarah et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 549-554, issn 0167-6806, 6 p.Article

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancerWIRTENBERGER, Michael; TCHATCHOU, Sandrine; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 11, pp 2201-2208, issn 0143-3334, 8 p.Article

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer riskRONGXI YANG; SCHLEHE, Bettina; ARNOLD, Norbert et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 693-702, issn 0167-6806, 10 p.Article

Association of a Common AKAP9 Variant With Breast Cancer Risk : A Collaborative AnalysisFRANK, Bernd; WIESTLER, Miriam; MEINDL, Alfons et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 6, pp 437-442, issn 0027-8874, 6 p.Article

SNPs in ultraconserved elements and familial breast cancer riskRONGXI YANG; FRANK, Bernd; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 2, pp 351-355, issn 0143-3334, 5 p.Article

Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expressionSCHÖNDORF, Thomas; HOOPMANN, Markus; EVERSHEIM, Barbara et al.Oncology reports. 2003, Vol 10, Num 6, pp 1717-1722, issn 1021-335X, 6 p.Article

The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersLAITMAN, Yael; KUCHENBAECKER, Karoline B; SCHMUTZLER, Rita K et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1119-1126, issn 0167-6806, 8 p.Article

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer riskFURU WANG; ZHIBIN HU; MEINDL, Alfons et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 769-775, issn 0167-6806, 7 p.Article

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersENGEL, Christoph; VERSMOLD, Beatrix; GARETH EVANS, D et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 11, pp 2859-2868, issn 1055-9965, 10 p.Article

The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancerWIRTENBERGER, Michael; SCHMUTZHARD, Julia; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 2, pp 423-426, issn 0143-3334, 4 p.Article

Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer riskVACLAVICEK, Annika; LORENZO BERMEJO, Justo; HEMMINKI, Kari et al.Breast cancer research and treatment. 2007, Vol 106, Num 2, pp 205-213, issn 0167-6806, 9 p.Article

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancerWIRTENBERGER, Michael; FRANK, Bernd; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 8, pp 1655-1660, issn 0143-3334, 6 p.Article

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivityBECKER, Alexandra A; GRAESER, Monika K; LANDWEHR, Christina et al.Breast cancer research and treatment. 2012, Vol 135, Num 1, pp 167-175, issn 0167-6806, 9 p.Article

Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriersDICK, Michelle G; VERSMOLD, Beatrix; KAST, Karin et al.International journal of cancer (Print). 2012, Vol 130, Num 6, pp 1314-1318, issn 0020-7136, 5 p.Article

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)MAVADDAT, Nasim; BARROWDALE, Daniel; MULLIGAN, Anna Marie et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 1, pp 134-147, issn 1055-9965, 14 p.Article

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneMEINDL, Alfons; HELLEBRAND, Heide; RAMSER, Juliane et al.Nature genetics. 2010, Vol 42, Num 5, pp 410-414, issn 1061-4036, 5 p.Article

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal womenTCHATCHOU, Sandrine; JUNG, Anke; DITSCH, Nina et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 1, pp 59-64, issn 0143-3334, 6 p.Article

Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancerWIRTENBERGER, Michael; TCHATCHOU, Sandrine; BURWINKEL, Barbara et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 3, pp 593-598, issn 0143-3334, 6 p.Article

Association of the ARLTS1 Cysl48Arg variant with familial breast cancer riskFRANK, Bernd; HEMMINKI, Kari; MEINDL, Alfons et al.International journal of cancer. 2006, Vol 118, Num 10, pp 2505-2508, issn 0020-7136, 4 p.Article

Polymorphisms in genes involved in GH1 release and their association with breast cancer riskWAGNER, Kerstin; HEMMINKI, Kari; PEKALA, Wioletta et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 9, pp 1867-1875, issn 0143-3334, 9 p.Article

Association of NCOA3 polymorphisms with breast cancer riskBURWINKEL, Barbara; WIRTENBERGER, Michael; BUTKIEWICZ, Dorota et al.Clinical cancer research. 2005, Vol 11, Num 6, pp 2169-2174, issn 1078-0432, 6 p.Article

  • Page / 1